Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 8530 | 24.04 |
09:34 ET | 3400 | 24.02 |
09:36 ET | 1916 | 23.91 |
09:38 ET | 800 | 23.97 |
09:39 ET | 5158 | 23.965 |
09:41 ET | 5263 | 24.01 |
09:43 ET | 600 | 23.99 |
09:45 ET | 2693 | 23.94 |
09:48 ET | 2950 | 23.94 |
09:50 ET | 2100 | 23.965 |
09:52 ET | 2206 | 23.94 |
09:54 ET | 300 | 23.91 |
09:56 ET | 1775 | 23.96 |
09:57 ET | 2209 | 23.925 |
09:59 ET | 2670 | 23.96 |
10:01 ET | 6293 | 23.94 |
10:03 ET | 2106 | 23.92 |
10:06 ET | 1600 | 23.945 |
10:08 ET | 540 | 23.955 |
10:10 ET | 6789 | 23.95 |
10:12 ET | 2203 | 23.91 |
10:15 ET | 1448 | 23.87 |
10:17 ET | 3882 | 23.87 |
10:19 ET | 14875 | 23.905 |
10:21 ET | 4283 | 23.89 |
10:24 ET | 500 | 23.895 |
10:26 ET | 1344 | 23.91 |
10:28 ET | 3203 | 23.9 |
10:30 ET | 1000 | 23.91 |
10:32 ET | 1022 | 23.909 |
10:33 ET | 800 | 23.935 |
10:35 ET | 3512 | 23.955 |
10:37 ET | 2765 | 23.965 |
10:39 ET | 10289 | 23.99 |
10:42 ET | 305 | 23.99 |
10:44 ET | 2183 | 24 |
10:46 ET | 8827 | 23.995 |
10:48 ET | 4550 | 24.01 |
10:50 ET | 6518 | 24.01 |
10:51 ET | 933 | 24.015 |
10:53 ET | 1300 | 24 |
10:55 ET | 753 | 23.995 |
10:57 ET | 1814 | 24.025 |
11:00 ET | 2431 | 24.045 |
11:02 ET | 1442 | 24.0425 |
11:04 ET | 500 | 24.045 |
11:06 ET | 6043 | 24.005 |
11:08 ET | 2208 | 24 |
11:09 ET | 2268 | 23.985 |
11:11 ET | 1711 | 24.02 |
11:13 ET | 2595 | 24 |
11:18 ET | 1042 | 24.02 |
11:20 ET | 211 | 24.025 |
11:22 ET | 8978 | 24.02 |
11:24 ET | 1370 | 24.04 |
11:26 ET | 3817 | 24.04 |
11:27 ET | 3791 | 24.03 |
11:29 ET | 2749 | 24.02 |
11:31 ET | 910 | 24.015 |
11:33 ET | 500 | 24.02 |
11:36 ET | 1082 | 24.02 |
11:38 ET | 61064 | 24.16 |
11:40 ET | 5274 | 24.17 |
11:42 ET | 11331 | 24.215 |
11:44 ET | 6157 | 24.2 |
11:45 ET | 604 | 24.17 |
11:47 ET | 400 | 24.13 |
11:49 ET | 2853 | 24.18 |
11:51 ET | 1538 | 24.22 |
11:54 ET | 2680 | 24.235 |
11:56 ET | 5545 | 24.22 |
11:58 ET | 1262 | 24.21 |
12:00 ET | 2594 | 24.21 |
12:02 ET | 1648 | 24.21 |
12:03 ET | 1320 | 24.2 |
12:05 ET | 700 | 24.18 |
12:07 ET | 2377 | 24.205 |
12:09 ET | 1409 | 24.2 |
12:12 ET | 1614 | 24.23 |
12:14 ET | 1800 | 24.26 |
12:16 ET | 2971 | 24.25 |
12:18 ET | 1518 | 24.24 |
12:20 ET | 2725 | 24.245 |
12:21 ET | 692 | 24.245 |
12:23 ET | 1100 | 24.245 |
12:25 ET | 15058 | 24.26 |
12:27 ET | 4148 | 24.245 |
12:30 ET | 8782 | 24.2558 |
12:32 ET | 782 | 24.25 |
12:34 ET | 649 | 24.25 |
12:36 ET | 6495 | 24.25 |
12:38 ET | 650 | 24.25 |
12:39 ET | 450 | 24.25 |
12:41 ET | 6922 | 24.26 |
12:43 ET | 400 | 24.25 |
12:45 ET | 968 | 24.25 |
12:48 ET | 2309 | 24.275 |
12:50 ET | 3499 | 24.27 |
12:52 ET | 2534 | 24.29 |
12:54 ET | 2757 | 24.295 |
12:56 ET | 1473 | 24.27 |
12:57 ET | 511 | 24.28 |
12:59 ET | 500 | 24.28 |
01:01 ET | 2997 | 24.23 |
01:03 ET | 5357 | 24.27 |
01:06 ET | 1033 | 24.28 |
01:08 ET | 100 | 24.27 |
01:10 ET | 100 | 24.27 |
01:12 ET | 3783 | 24.305 |
01:14 ET | 1105 | 24.315 |
01:15 ET | 1030 | 24.315 |
01:17 ET | 1492 | 24.325 |
01:19 ET | 3584 | 24.34 |
01:21 ET | 2506 | 24.335 |
01:24 ET | 2493 | 24.335 |
01:26 ET | 2654 | 24.3468 |
01:28 ET | 4487 | 24.345 |
01:30 ET | 8842 | 24.36 |
01:32 ET | 15297 | 24.3248 |
01:33 ET | 100 | 24.33 |
01:35 ET | 2427 | 24.335 |
01:37 ET | 2189 | 24.355 |
01:39 ET | 5043 | 24.37 |
01:42 ET | 2447 | 24.37 |
01:44 ET | 690 | 24.36 |
01:46 ET | 5060 | 24.3701 |
01:48 ET | 4383 | 24.385 |
01:50 ET | 2085 | 24.39 |
01:51 ET | 4932 | 24.42 |
01:53 ET | 3098 | 24.4 |
01:57 ET | 13102 | 24.41 |
02:00 ET | 300 | 24.41 |
02:02 ET | 7460 | 24.43 |
02:04 ET | 2100 | 24.45 |
02:06 ET | 10636 | 24.52 |
02:08 ET | 1707 | 24.515 |
02:09 ET | 11407 | 24.505 |
02:11 ET | 32361 | 24.59 |
02:13 ET | 3799 | 24.63 |
02:15 ET | 6899 | 24.55 |
02:18 ET | 1845 | 24.6 |
02:20 ET | 1628 | 24.605 |
02:22 ET | 4044 | 24.65 |
02:24 ET | 2437 | 24.63 |
02:26 ET | 800 | 24.645 |
02:27 ET | 8917 | 24.71 |
02:29 ET | 2503 | 24.735 |
02:31 ET | 5182 | 24.755 |
02:33 ET | 5569 | 24.76 |
02:36 ET | 2850 | 24.76 |
02:38 ET | 3321 | 24.75 |
02:40 ET | 2303 | 24.755 |
02:42 ET | 3215 | 24.745 |
02:44 ET | 800 | 24.755 |
02:45 ET | 2100 | 24.75 |
02:47 ET | 1568 | 24.755 |
02:49 ET | 1700 | 24.765 |
02:51 ET | 2949 | 24.75 |
02:54 ET | 2580 | 24.745 |
02:56 ET | 1582 | 24.735 |
02:58 ET | 2354 | 24.72 |
03:00 ET | 2539 | 24.71 |
03:02 ET | 1764 | 24.7 |
03:03 ET | 4913 | 24.745 |
03:05 ET | 2592 | 24.77 |
03:07 ET | 2301 | 24.765 |
03:09 ET | 11279 | 24.79 |
03:12 ET | 7683 | 24.825 |
03:14 ET | 6011 | 24.835 |
03:16 ET | 13421 | 24.8346 |
03:18 ET | 16371 | 24.79 |
03:20 ET | 5899 | 24.83 |
03:21 ET | 10954 | 24.825 |
03:23 ET | 5436 | 24.845 |
03:25 ET | 63777 | 24.85 |
03:27 ET | 5323 | 24.86 |
03:30 ET | 7186 | 24.881 |
03:32 ET | 7605 | 24.875 |
03:34 ET | 5807 | 24.88 |
03:36 ET | 4789 | 24.885 |
03:38 ET | 11829 | 24.935 |
03:39 ET | 8017 | 24.965 |
03:41 ET | 17736 | 24.959 |
03:43 ET | 16293 | 24.95 |
03:45 ET | 9271 | 24.9 |
03:48 ET | 12074 | 24.865 |
03:50 ET | 5458 | 24.85 |
03:52 ET | 8966 | 24.88 |
03:54 ET | 13904 | 24.95 |
03:56 ET | 40027 | 24.875 |
03:57 ET | 21757 | 24.83 |
03:59 ET | 48850 | 24.79 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.1B | 7.1x | --- |
Exelixis Inc | 6.4B | 34.1x | -21.77% |
PTC Therapeutics Inc | 2.9B | -4.9x | --- |
Novavax Inc | 2.2B | -5.3x | --- |
P3 Health Partners Inc | 202.4M | -1.1x | --- |
Ionis Pharmaceuticals Inc | 5.8B | -14.9x | --- |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.44 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 7.1x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 6.2x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.